Natural Anti-inflammatory Compounds as Drug Candidates in Alzheimer’s Disease

  • Mir R
  • Shah A
  • Mohi-ud-din R
  • et al.
87Citations
Citations of this article
46Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Alzheimer's disease (AD) is a chronic neurodegenerative brain disorder characterized by memory impairment, dementia, and oxidative stress in elderly people. Currently, only a few drugs are available in the market with various adverse effects. Therefore, to develop new drugs with protective action against the disease, research is turning to the identification of plant products as a remedy. Natural compounds with anti-inflammatory activity could be good candidates for developing effective therapeutic strategies. Phytochemicals, including Curcumin, Resveratrol, Quercetin, Huperzine-A, Rosmarinic acid, genistein, obovatol, and Oxyresvertarol, were reported molecules for the treatment of AD. Several alkaloids, such as galantamine, oridonin, glaucocalyxin B, tetrandrine, berberine and anatabine, have been shown anti-inflammatory effects in AD models in vitro as well as in-vivo. In conclusion, natural products from plants represent interesting candidates for the treatment of AD. This review highlights the potential of specific compounds from natural products along with their synthetic derivatives to counteract AD in the CNS. © 2022 Elsevier B.V., All rights reserved.

Cite

CITATION STYLE

APA

Mir, R. H., Shah, A. J., Mohi-ud-din, R., Pottoo, F. H., Dar, Mohd. A., Jachak, S. M., & Masoodi, M. H. (2020). Natural Anti-inflammatory Compounds as Drug Candidates in Alzheimer’s Disease. Current Medicinal Chemistry, 28(23), 4799–4825. https://doi.org/10.2174/0929867327666200730213215

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free